Clinical Trial

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 20, 2025 (before its estimated March 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
The open-label prospective non-randomised controlled aims to assess the efficacy of the combination of immunosupression (IST) and tonsillectomy (TE) in Caucasian patients at high risk of the IgA-nephropathy.
Trial Details
NCT Number NCT07074951
Lead Sponsor St. Petersburg State Pavlov Medical University
Conditions Primary IgA-nephropathy, High-risk, Caucasians
Enrollment 240 participants
Start Date 2013-03-10
Primary Completion 2026-03-10 (estimated)
Study Completion 2027-12-10 (estimated)
Updated on ClinicalTrials.gov 2025-07-20